NEARVUE Trademark

Trademark Overview


On Friday, March 12, 2021, a trademark application was filed for NEARVUE with the United States Patent and Trademark Office. The USPTO has given the NEARVUE trademark a serial number of 90576817. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by Visus Therapeutics Inc.. The NEARVUE trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic drugs
nearvue

General Information


Serial Number90576817
Word MarkNEARVUE
Filing DateFriday, March 12, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2021

Trademark Statements


Goods and ServicesOphthalmic drugs
Pseudo MarkNEAR VUE; NEAR VIEW

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVisus Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameVisus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2022SOU EXTENSION 1 GRANTED
Friday, March 4, 2022SOU EXTENSION 1 FILED
Friday, March 4, 2022TEAS EXTENSION RECEIVED
Friday, October 29, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 29, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 29, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 20, 2021ASSIGNED TO EXAMINER
Monday, June 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 16, 2021NEW APPLICATION ENTERED

Related Keywords


nearvue drugs ophthalmic